CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy

Huiyuan Bai; Tao Wang; Fei Kong; Meichen Zhang; Zhuoxuan Li; Linlin Zhuang; Ming Ma; Fangzhou Liu; Chen Wang; Haiyan Xu; Ning Gu; Yu Zhang

doi:10.1016/j.cej.2020.126891

JOURNAL ARTICLE

CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy

Huiyuan Bai Tao Wang Fei Kong Meichen Zhang Zhuoxuan Li Linlin Zhuang Ming Ma Fangzhou Liu Chen Wang Haiyan Xu Ning Gu Yu Zhang

Year: 2020 Journal: Chemical Engineering Journal Vol: 405 Pages: 126891-126891 Publisher: Elsevier BV

DOI: 10.1016/j.cej.2020.126891

Get Full-Text PDF Get Analytical Report

Keywords:

Myeloid leukemia Daunorubicin Cancer research Chemistry Bone marrow Targeted therapy Medicine Leukemia Pharmacology Immunology Internal medicine Cancer

Metrics

Cited By

1.81

FWCI (Field Weighted Citation Impact)

Refs

0.85

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Chemokine receptors and signaling

Health Sciences → Medicine → Oncology

RNA Interference and Gene Delivery

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Advanced biosensing and bioanalysis techniques

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy

Metrics

Citation History

Topics

Related Documents

Hollow Mesoporous Prussian Blue Nanoparticles Loaded with Daunorubicin for Acute Myeloid Leukemia Treatment

Targeted Therapy of Acute Myeloid Leukemia

Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia

Carrier-Free Peptide–Daunorubicin–Small Interfering RNA Nanoassembly for Targeted Therapy of Acute Myeloid Leukemia

CD123-targeted therapy in acute myeloid leukemia